8-K filing — JUPITER NEUROSCIENCES, INC. (JUNS)
Filed: 2026-09-03 AccNo: 0001493152-26-041315 Size: 212 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits
Stocks · News reference
Jupiter Neurosciences shares are trading higher after the company's related biotechnology partner, PharmAla Biotech Holdings, announced a series of corporate updates, including a newly granted U.S. patent.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Dow Falls Over 300 Points; SAIC Shares Jump After Upbeat Q2 Results
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Monday. Following the market opening Monday, the Dow traded down 0.61% to 53,232.50 while the NASDAQ slipped 0.45% to
Why Webuy Global Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Shares of Webuy Global Ltd (NASDAQ:WBUY) rose sharply in pre-market trading. Webuy reported record preliminary unaudited travel bookings of around $4.76 million during the three-day NATAS Fair in Aug. 2026,
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Picard Medical (AMEX:PMI) shares moved upwards by 82.7% to $9.38 during Tuesday's regular session. The market value of their outstanding shares is at $10.5 million. As per the news, the Q2 earnings report